PhenomeX Inc. (NASDAQ: CELL) to Merge with Bruker Corporation in Strategic Acquisition
Amongst a challenging funding landscape, PhenomeX emerges by clinching an irresistible deal With Bruker. Here's more on the transaction.
Source: microcapdaily.com